RECRUITINGINTERVENTIONAL

Early Life Intervention in Pediatrics Supported by E-health

Early Life Intervention in Pediatrics Supported by E-health (ELIPSE I): Coaching Parents to Lower Obesity in Children. A Single-blind Randomized Controlled Parallel-group Clinical Trial.

About This Trial

Childhood obesity in early life contributes to the development of specific NCDs, i.e. adult obesity. Unhealthy diet and low level of physical activity are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of NCDs. Early preventive measures to improve lifestyle behavior are of utmost importance. The aim of ELIPSE-I is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering total energy intake/total energy expenditure (TEI/TEE) ratio in their children with BMI \>97 centile (ELIPSE-I).

Who May Be Eligible (Plain English)

Who May Qualify: - German speaking parents - Any ethnic background/race - Children should live/grow-up in the same household as the parental participant - Children with an age- and sex-matched BMI \>97 centile according to Swiss national growth charts - Children who attend the outpatient weight management clinic at the Division of Pediatric Endocrinology at the University Children's Hospital Bern - Signed willing to sign a consent form form from parent(s) Who Should NOT Join This Trial: - Syndromic obesity - Known congenital disease affecting musculo-skeletal, cardiac or pulmonary function - Participation in another clinical trial targeting similar objectives Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * German speaking parents * Any ethnic background/race * Children should live/grow-up in the same household as the parental participant * Children with an age- and sex-matched BMI \>97 centile according to Swiss national growth charts * Children who attend the outpatient weight management clinic at the Division of Pediatric Endocrinology at the University Children's Hospital Bern * Signed informed consent form from parent(s) Exclusion Criteria: * Syndromic obesity * Known congenital disease affecting musculo-skeletal, cardiac or pulmonary function * Participation in another clinical trial targeting similar objectives

Treatments Being Tested

BEHAVIORAL

Life-Style app

The modules of the Life-Style app are introduced and unlocked sequentially during the first weeks of the intervention phase. Afterwards the modules are fully available. Duration and frequency of app-use is not limited. The parents are accompanied by a coach through the app, who gives regular structured feedback and individual inputs. The coach has access to all data collected in the app.

Locations (1)

Department of Paediatrics, Inselspital, Bern University Hospital

Bern, Switzerland